BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6409439)

  • 1. Preferential binding of aflatoxin B1 to the transcriptionally active regions of rat liver nucleolar chromatin in vivo and in vitro.
    Yu FL
    Carcinogenesis; 1983; 4(7):889-93. PubMed ID: 6409439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation studies between the binding of aflatoxin B1 to chromatin components and the inhibition of RNA synthesis.
    Yu FL; Geronimo IH; Bender W; Permthamsin J
    Carcinogenesis; 1988 Apr; 9(4):527-32. PubMed ID: 3128406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of aflatoxin B1 inhibition of rat liver nucleolar RNA synthesis.
    Yu FL
    J Biol Chem; 1981 Apr; 256(7):3292-7. PubMed ID: 6162844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the transcription os physiologically inactive rat-liver nucleolar chromatin by Escherichia coli RNA polymerase.
    Yu FL; Barrett A
    Biosci Rep; 1982 Mar; 2(3):155-61. PubMed ID: 6175357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinomycin D-binding in vivo: active chromatin preferred.
    Yu FL
    FEBS Lett; 1983 May; 156(1):83-7. PubMed ID: 6343119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of aflatoxin B1 to rat liver nuclear proteins and its effect on DNA-dependent RNA synthesis.
    Yu FL; Bender W; Geronimo IH
    Carcinogenesis; 1988 Apr; 9(4):533-40. PubMed ID: 2451574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actinomycin D binding in vitro: active chromatin preferred.
    Yu FL; Bender W
    Biochem Int; 1990; 20(4):807-15. PubMed ID: 1693849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pre-treatment with phenobarbitone on the activation of aflatoxin B1 by rat liver.
    Neal GE; Godoy HM
    Chem Biol Interact; 1976 Aug; 14(3-4):279-89. PubMed ID: 954146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some studies of the effects of aflatoxin B1 in vivo and in vitro on nucleic acid synthesis in rat and mouse.
    Godoy HM; Neal GE
    Chem Biol Interact; 1976 Jun; 13(3-4):257-77. PubMed ID: 1269046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of aflatoxin B1 on the transcriptional activity of DNA template, chromatin and soluble DNA-dependent RNA polymerases in buffalo liver.
    Mashaly RI; Habib SL; Salem MH; el Deeb SA; Safwat MM; Sarhan F
    Toxicol Lett; 1988 Apr; 41(1):69-75. PubMed ID: 3128897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fidelity of ribosomal ribonucleic acid synthesis by nucleoli and nucleolar chromatin.
    Matsui SI; Fuke M; Busch H
    Biochemistry; 1977 Jan; 16(1):39-45. PubMed ID: 188446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in DNA-dependent RNA polymerase I and II from rat liver by thioacetamide: preferential increase in the level of chromatin-associated nucleolar RNA polymerase IB.
    Leonard TB; Jacob ST
    Biochemistry; 1977 Oct; 16(20):4538-44. PubMed ID: 911772
    [No Abstract]   [Full Text] [Related]  

  • 13. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
    Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
    Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.
    Lin JK; Miller JA; Miller EC
    Cancer Res; 1977 Dec; 37(12):4430-8. PubMed ID: 922734
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation by some natural carotenoids of DNA adduct formation by aflatoxin B1 in vitro.
    Goswami UC; Saloi TN; Firozi PF; Bhattacharya RK
    Cancer Lett; 1989 Sep; 47(1-2):127-32. PubMed ID: 2517591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo disposition of aflatoxin B1 in rat liver.
    Ewaskiewicz JI; Devlin TM; Ch'ih JJ
    Biochem Biophys Res Commun; 1991 Sep; 179(2):1095-100. PubMed ID: 1910338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase.
    Chetsanga CJ; Frenette GP
    Carcinogenesis; 1983 Aug; 4(8):997-1000. PubMed ID: 6409445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.